Fludarabine
FT1050-01
Phase 1 small_molecule completed
Quick answer
Fludarabine for Hematologic Malignancies is a Phase 1 program (small_molecule) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- Hematologic Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed